Back to results
US 2014/0271465 A1Published application
Matrix metalloprotease (mmp) targeted agents for imaging and therapy
AssigneeMallinckrodt Inc.
InventorsJohn N. Freskos, Mary Dyszlewski, Lori Chinen, Hector Knight, Michelle Schmidt
Life of this patent
Estimating the term…
Abstract
The present invention provides compound conjugates of matrix metalloprotease inhibitors and linked metal chelators which are useful for imaging solid tumors and treating and diagnosing certain types of diseases such as cancer.
Claims20
A compound conjugate comprising a matrix metalloprotease inhibitor (MMPi) portion and a linked metal chelator portion.
A method of diagnosing the presence of solid tumors in a patient, the method comprising the following steps:
- administering a compound conjugate comprising a matrix metalloprotease inhibitor (MMPi) portion and a linked metal chelator portion to a patient;
- acquiring a contrast image of the administered conjugate, or fragment thereof, in the patient;
- analyzing said contrast image to determine the concentration of MMP enzymes;
- and;
- diagnosing the presence of solid tumors based on said determination of the concentration of MMP enzymes;
- wherein a locally high concentration of MMP enzymes indicates a diagnosis of solid tumors.
3 more elements
A method for treating a patient having solid tumors, the method comprising:
- administering a compound conjugate comprising a matrix metalloprotease inhibitor (MMPi) portion and a linked metal chelator portion to a patient having solid tumors;
- thereby treating a patient having solid tumors.
Dependencies are inferred from the claim text.